Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform
Telangiectases, Port Wine Stain
About this trial
This is an interventional treatment trial for Telangiectases focused on measuring Vascular lesions, Intense pulse light, phototermolysis, wavelength, filters, non coherent
Eligibility Criteria
Inclusion Criteria: Healthy Subjects, presenting with at least one of the clinical indications mentioned above Willing and being able to comply with all visit and evaluation requirements Willing and being able to provide signed Informed Consent Exclusion Criteria: A history of keloid scar formation or poor wound healing Wounded or tanned in area to be treated Pregnant or intending to become pregnant during the evaluation period Subjects with a bleeding disorder or who take anticoagulation medications Significant concurrent illnesses, such as diabetes, epilepsy, lupus or congestive heart failure Significant concurrent skin conditions affecting area to be treated Having a history of skin cancer or any other cancer in the area to be treated History of immunosuppressive disease
Sites / Locations
- Plastic surgery dept., Rambam medical center